Last reviewed · How we verify
Discontibuation of oral ULT — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Discontibuation of oral ULT (Discontibuation of oral ULT) — Assistance Publique - Hôpitaux de Paris.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Discontibuation of oral ULT TARGET | Discontibuation of oral ULT | Assistance Publique - Hôpitaux de Paris | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Discontibuation of oral ULT CI watch — RSS
- Discontibuation of oral ULT CI watch — Atom
- Discontibuation of oral ULT CI watch — JSON
- Discontibuation of oral ULT alone — RSS
Cite this brief
Drug Landscape (2026). Discontibuation of oral ULT — Competitive Intelligence Brief. https://druglandscape.com/ci/discontibuation-of-oral-ult. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab